Activated T cells and cytokine-induced CD3(+)CD56(+) killer cells

被引：219

作者：

SchmidtWolf, GD

Negrin, RS

SchmidtWolf, IGH

机构：

[1] HUMBOLDT UNIV BERLIN,VIRCHOW CLIN,DEPT MED,DIV HEMATOL ONCOL,D-13353 BERLIN,GERMANY

[2] STANFORD UNIV,MED CTR,BONE MARROW TRANSPLANTAT PROGRAM,STANFORD,CA 94305

来源：

ANNALS OF HEMATOLOGY | 1997年 / 74卷 / 02期

关键词：

T cells; cytokine-induced killer cells; immunotherapy;

D O I：

10.1007/s002770050257

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Over the past two decades, attempts have been made to develop immunotherapy for patients with cancer. A significant obstacle to the development of successful adoptive immunotherapy has been the availability of appropriate cytotoxic cells. Immunologic effector cells such as lymphokine-activated killer (LAK) cells, activated T cells such as tumor-infiltrating lymphocytes (TILs), and cytokine-induced killer (CIK) cells may be suitable to remove residual tumor cells.

引用

页码：51 / 56

页数：6

共 49 条

[1]

ALDER A, 1988, BLOOD, V71, P709

[2] INDUCIBILITY OF LYMPHOKINE ACTIVATED KILLER (LAK) CELLS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA IN COMPLETE REMISSION AND ITS CLINICAL RELEVANCE [J].